Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue

Clinical trial NCT01794429 · COMPLETED

Trial details

NCT number: NCT01794429
Sponsor: Bjorn H. Ebdrup
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Metabolic Syndrome X Drug-induced Obesity Schizophrenia

Start date: 2013-02-01
Primary completion: 2015-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.